Regulatory T cells that express high levels of IL-1R and ICOS display transcriptional features of antigen specificity, are highly suppressive and distinguish tumors from non-malignant inflamed tissues
References
Martins, F. et al. Nat. Rev. Clin. Oncol. 16, 563–580 (2019).
Mair, F. et al. Nature 605, 728–735 (2022).
Greene, E. et al. Patterns (N Y) 2, 100372 (2021).
Browaeys, R., Saelens, W. & Saeys, Y. Nat. Methods 17, 159–162 (2020).
Ahmadzadeh, M. et al. Sci. Immunol. https://doi.org/10.1126/sciimmunol.aao4310 (2019).
Jain, A., Song, R., Wakeland, E. K. & Pasare, C. Nat. Commun. 9, 3185 (2018).
Fu, T., He, Q. & Sharma, P. Cancer Res. 71, 5445–5454 (2011).
Simpson, T. R. et al. J. Exp. Med. 210, 1695–1710 (2013).
Solomon, I. et al. Nat. Can. 1, 1153–1166 (2020).
Kidani, Y. et al. Proc. Natl Acad. Sci. USA 119, e2114282119 (2022).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Gálvez-Cancino, F., Lladser, A. & Quezada, S.A. Deciphering immunoregulatory vulnerabilities in human cancers. Nat Immunol 23, 995–996 (2022). https://doi.org/10.1038/s41590-022-01251-w
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41590-022-01251-w
- Springer Nature America, Inc.